| Followers | 42 |
| Posts | 8587 |
| Boards Moderated | 2 |
| Alias Born | 11/23/2003 |
Tuesday, February 24, 2015 9:03:50 AM
***PKTX.. PROTOKINETIX, INCORPORATED.
9176 South Pleasants Highway
St. Marys, WV 26170
..ProtoKinetix Announces New President and Chief Executive Officer
February 23, 2015
...ProtoKinetix, Incorporated (OTC: PKTX) (www.protokinetix.com) (the "Company" or "ProtoKinetix") announces that a cease trade order issued by the British Columbia Securities Commission was revoked effective as of the date of this news release.
..In connection with the revocation, the Company also announces that it has received and accepted the resignation of Mr. Ross Senior as a Director, President and Chief Executive Officer of the Company effective as of February 19, 2015. Mr. Clarence E. Smith has been appointed as the Company's new President and Chief Executive Officer.
..ProtoKinetix further announces that it has moved its head office to 9176 South Pleasants Highway, St. Marys, West Virginia, USA 26170.
About ProtoKinetix
ProtoKinetix is a molecular biotechnology company that has developed and patented a family of hyper stable, potent glycopeptides (AAGP™) that dramatically enhance the therapeutic results and reduce the cost of stem cell medicine. Due to the anti-inflammatory effect of AAGP™ molecules, the Company is currently targeting the direct treatment of diseases that have a major inflammatory component.
ON BEHALF OF THE BOARD OF DIRECTORS
PROTOKINETIX, INCORPORATED
Clarence E. Smith
President and Chief Executive Officer
For further information, please contact:
Clarence E. Smith, President & Chief Executive Officer
Telephone: 304-299-5070
Email: csmith@protokinetix.com
9176 South Pleasants Highway
St. Marys, WV 26170
..ProtoKinetix Announces New President and Chief Executive Officer
February 23, 2015
...ProtoKinetix, Incorporated (OTC: PKTX) (www.protokinetix.com) (the "Company" or "ProtoKinetix") announces that a cease trade order issued by the British Columbia Securities Commission was revoked effective as of the date of this news release.
..In connection with the revocation, the Company also announces that it has received and accepted the resignation of Mr. Ross Senior as a Director, President and Chief Executive Officer of the Company effective as of February 19, 2015. Mr. Clarence E. Smith has been appointed as the Company's new President and Chief Executive Officer.
..ProtoKinetix further announces that it has moved its head office to 9176 South Pleasants Highway, St. Marys, West Virginia, USA 26170.
About ProtoKinetix
ProtoKinetix is a molecular biotechnology company that has developed and patented a family of hyper stable, potent glycopeptides (AAGP™) that dramatically enhance the therapeutic results and reduce the cost of stem cell medicine. Due to the anti-inflammatory effect of AAGP™ molecules, the Company is currently targeting the direct treatment of diseases that have a major inflammatory component.
ON BEHALF OF THE BOARD OF DIRECTORS
PROTOKINETIX, INCORPORATED
Clarence E. Smith
President and Chief Executive Officer
For further information, please contact:
Clarence E. Smith, President & Chief Executive Officer
Telephone: 304-299-5070
Email: csmith@protokinetix.com
Recent PKTX News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 08:15:23 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/23/2025 06:11:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 04:57:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/19/2025 10:19:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 01:36:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 08:58:10 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/15/2025 09:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/05/2025 08:15:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 05:30:59 PM
